1. Home
  2. COEP

COEP

Coeptis Therapeutics Holdings Inc.

Logo Coeptis Therapeutics Holdings Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-19-2024 12:29pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Founded: 2017 Country:
United States
United States
Employees: N/A City: WEXFORD
Market Cap: 14.0M IPO Year: N/A
Target Price: $5.67 AVG Volume (30 days): 264.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.83 EPS Growth: N/A
52 Week Low/High: $0.28 - $2.19 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: